Cargando…
Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model
Autologous neural stem cells (NSCs) may offer a promising source for deriving dopaminergic (DA) cells for treatment of Parkinson's disease (PD). Methods: By using Sendai virus, human peripheral blood mononuclear cells (PBMNCs) were reprogrammed to induced NSCs (iNSCs), which were then different...
Autores principales: | Yuan, Yanpeng, Tang, Xihe, Bai, Yun-Fei, Wang, Shuyan, An, Jing, Wu, Yanchuan, Xu, Zhi-Qing David, Zhang, Y. Alex, Chen, Zhiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160767/ https://www.ncbi.nlm.nih.gov/pubmed/30279731 http://dx.doi.org/10.7150/thno.26643 |
Ejemplares similares
-
Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons
por: Boyd, Rachel J., et al.
Publicado: (2023) -
Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons
por: Boyd, Rachel J., et al.
Publicado: (2023) -
Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons
por: Boyd, Rachel J., et al.
Publicado: (2023) -
Neuronal precursor cells with dopaminergic commitment in the rostral migratory stream of the mouse
por: Schweyer, Kerstin, et al.
Publicado: (2019) -
Influence of Depressive Symptoms on Dopaminergic Treatment of Parkinson’s Disease
por: Hanganu, Alexandru, et al.
Publicado: (2014)